SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is trending as investors react to a significant push for federal cannabis reform, with the community closely tracking the upcoming DEA hearings that could impact the entire MSO sector. Sentiment remains split between long-term holders accumulating shares based on fundamental growth and retail traders expressing frustration over ongoing price volatility and the slow pace of institutional capital deployment.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is trending as investors debate whether the recent price decline represents a deep-value buying opportunity or a terminal collapse for the DeFi protocol. While some community members highlight its low circulating supply and potential for an institutional-led recovery, others express significant frustration over persistent downward pressure and concerns regarding project fundamentals.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is trending as investors debate its long-term potential as a reliable payment network and digital silver, with community members actively discussing technical chart patterns, supply scarcity, and recent institutional developments. While some participants are closely tracking potential reversal signals and support levels, others remain focused on the broader thesis of Litecoin as a battle-tested infrastructure play within the proof-of-work sector.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is trending as the community eagerly anticipates an upcoming Ethereum mainnet expansion and the implementation of a new predictive allocation mechanism. Investors are actively debating the token's long-term utility as a liquidity hub for the Base ecosystem, with sentiment split between those accumulating on price weakness and others cautious of broader crypto market volatility.

Coeur Mining, Inc. engages in the well-diversified, growing precious metals producer with a focus on generating sustainable, high-quality cash flow and returns from a balanced, prospective asset base in mining-friendly jurisdictions along with commitment to exploration and expansions. It operates through the following segments: Palmarejo, Rochester, Kensington, Wharf and Silvertip. The Palmarejo segment includes a gold-silver complex. The Rochester segment operates an open pit heap leach silver-gold mine in northwestern Nevada. The Kensington segment relates to an underground gold mine located north of Juneau, Alaska. The Wharf segment focuses on an open pit heap leach gold mine located near Lead, South Dakota. The Silvertip segment silver-zinc-lead exploration located in the state of Sonora in northern Mexico. The company was founded in 1928 and is headquartered in Chicago, IL.

Coeur Mining Inc

Coeur Mining is attracting significant attention as investors position themselves ahead of the upcoming Q4 earnings report and the finalizing of the New Gold merger. Community sentiment is largely bullish, with traders actively discussing the company's strong free cash flow projections, potential for a stock buyback, and the massive leverage it provides to rising precious metal prices.

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF (MAGS) is a central point of discussion as investors debate whether recent price weakness represents a healthy consolidation or a warning sign for the broader AI-driven bull market. Community sentiment is currently polarized between those viewing this as an opportunistic rotation into oversold mega-caps and others who fear that unsustainable capital expenditure and shifting macroeconomic conditions signal a looming peak for the group.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber, Inc. is trending as investors aggressively position themselves ahead of upcoming quarterly earnings and the highly anticipated Cerebras Systems IPO, viewing the stock as a strategic proxy for AI compute demand. Community sentiment is driven by the companys recent infrastructure contracts and its role in the AI data center buildout, though discussions also reflect high volatility and skepticism regarding leadership and execution.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

Rigel Pharmaceuticals is currently a focal point for investors due to its recent acquisition of Veppanu, the first FDA-approved oral PROTAC therapy for breast cancer, which the community views as a potential blockbuster revenue driver that could transform the company's valuation. While some market participants express frustration over persistent short interest and a perceived lack of aggressive growth from leadership, bulls are positioning for upcoming clinical data readouts and potential licensing deals that could serve as major catalysts.

Horizon Quantum Holdings Ltd. engages in the development of software tools. The company is headquartered in Singapore.

Horizon Quantum Holdings Ltd. - Ordinary Shares - Class A

Horizon Quantum is capturing market attention as investors identify it as a potentially pivotal pure-play software provider in the quantum computing ecosystem. The stock is seeing heightened volatility and interest driven by its ultra-low float and strategic partnerships with major hardware players, leading the community to actively debate its long-term valuation relative to peers.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra Corp is trending as investors weigh its role as a critical power provider for AI-driven data centers against recent technical volatility and institutional trading patterns. The community is actively debating the company's valuation and long-term upside as a core infrastructure play, with many users focusing on its strategic nuclear and grid assets while closely monitoring key support levels for potential accumulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lifecore Biomedical (NASDAQ:LFCR) Posts Quarterly Earnings Results, Misses Expectations By $0.19 EPS

Lifecore Biomedical (NASDAQ:LFCR - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.43) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by ($0.19). Lifecore Biomedical had a negative return on equity of 1,211.09% and a negative net margin of...

Lifecore Biomedical Q1 Earnings Call Highlights

Lifecore Biomedical (NASDAQ:LFCR) executives highlighted new commercial site transfer wins, continued cost reductions, and improving liquidity during the company's first-quarter 2026 earnings call...

Lifecore Biomedical Q1 2026 Earnings Call Transcript

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Given Average Recommendation of "Hold" by Brokerages

Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) has been assigned a consensus recommendation of 'Hold' from the five brokerages that are currently covering the company, Marketbeat.com...

Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $6.00

Barrington Research upped their target price on Lifecore Biomedical from $5.50 to $6.00 and gave the stock an "outperform" rating in a research note on Wednesday...

Lifecore Biomedical (LFCR) to Release Earnings on Tuesday

Lifecore Biomedical (NASDAQ:LFCR) will be releasing earnings after the market closes on Tuesday, May 5. (View Earnings Report at...

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Receives Average Recommendation of "Hold" from Analysts

Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) have received a consensus recommendation of "Hold" from the five brokerages that are covering the firm, MarketBeat reports. One...

Lifecore Biomedical (LFCR) to Release Earnings on Thursday

Lifecore Biomedical (NASDAQ:LFCR) will be releasing earnings after the market closes on Thursday, April 2. (View Earnings Report at...

Lifecore Biomedical (NASDAQ:LFCR) Earns Outperform Rating from Barrington Research

Barrington Research reiterated an "outperform" rating and issued a $5.50 price target on shares of Lifecore Biomedical in a research report on Tuesday...

Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029

Lifecore Biomedical (NASDAQ:LFCR) CEO Paul Josephs told investors at a KeyBanc conference that the company has completed its transition into a standalone CDMO after divesting its former food...

Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.

Lifecore Biomedical Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

LFCRLifecore Biomedical Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LFCR News